middle.news
Island Pharmaceuticals Secures Singapore Patent for ISLA-101 Antiviral Treatment
9:38am on Thursday 2nd of July, 2026 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Secures Singapore Patent for ISLA-101 Antiviral Treatment
9:38am on Thursday 2nd of July, 2026 AEST
Key Points
Singapore patent granted for ISLA-101 antiviral use
Protection extends to Dengue and Chikungunya viruses
Patent valid until April 2034 for commercial exclusivity
Enhances Island’s positioning in Asia-Pacific region
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE